Converge, Inc. – Trademark Portfolio
Entity Type: 03
Converge, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CONVERGE and CONVERGEELEMENTS. The owner is based in Cupertino, CA.
10400 Ridgeview Court Suite 100
Cupertino, CA 95014
Showing of trademarks Trademarks
Trademark Classifications
Converge, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Converge, Inc. have?
Converge, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 5 registered, 8 abandoned.
What trademark classes does Converge, Inc. file in?
Converge, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.
What are Converge, Inc.'s most well-known trademarks?
Converge, Inc.'s registered trademark portfolio includes well-known marks such as CONVERGE and CONVERGEELEMENTS. These are among 5 currently registered trademarks in the portfolio.
What is Converge, Inc.'s trademark registration success rate?
Converge, Inc. has a 38% trademark registration rate, with 5 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.